Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Wednesday, 28 August 2019

Investorideas.com - Apeks Supercritical Expands Global Headquarters with Opening of New Manufacturing Facility in Ohio

Investorideas.com - Apeks Supercritical Expands Global Headquarters with Opening of New Manufacturing Facility in Ohio

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Paragon Processing, the Largest Operating Hemp Processing Facility in the US, Now Open for Business

Investorideas.com - Paragon Processing, the Largest Operating Hemp Processing Facility in the US, Now Open for Business

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $ISH.C) (CSE: $VAPN.C) (OTCQB: $DIGP) (CSE: $TER.C) (CSE: $OH.C)


Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $ISH.C) (CSE: $VAPN.C) (OTCQB: $DIGP) (CSE: $TER.C) (CSE: $OH.C)



Delta, Kelowna, BC –August 28, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today's podcast overview/transcript

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

But first, Scott McLeod, Gimaa (Chief) of the Nipissing First Nations, Ontario, commented on recent developments between the Ontario government and the Nipissing First Nations. "Last week the Province of Ontario exercised authority outside of its jurisdiction by issuing eight cannabis retail licenses to First Nations communities. The Cannabis Act has downgraded the autonomy of First Nations to maintain jurisdiction and create laws in our own territories by forcing us to work with the Provinces instead of the Crown. First Nations must have fair access to the economic potential to benefit our communities that the lawful cannabis industry presents yet we are unnecessarily held back because an error in the legislation is not being addressed because of an impending election. Our communities cannot wait for the government to play politics with our sovereignty or our potential to create jobs and economic opportunities for our people. Our communities have been actively reaching out to Canadian Government officials urging them to address this issue because we cannot afford to wait and be left behind once again."

Inner Spirit Holdings Ltd.  (CSE:ISH), a Canadian company establishing a national network of retail cannabis stores under its Spiritleaf brand, today announced it has filed its interim Financial Statements and corresponding Management's Discussion and Analysis for the quarter ended June 30, 2019. The filings are available for review on the Company's SEDAR profile at www.sedar.com as well as on the Company's website at www.innerspiritholdings.com.

"The lifting of the moratorium on cannabis retail store licences by Alberta Gaming, Liquor and Cannabis (the "AGLC") during the second quarter was precisely the springboard needed for Spiritleaf to advance its business strategy. We also completed an over-subscribed $10 million financing in the quarter to help us further support the Spiritleaf franchise network as well as open corporate-owned retail cannabis stores in select locations. During the second quarter, we had six Spiritleaf cannabis retail stores open, operating and generating financial results for the full period. By the end of the third quarter, we're projecting our operations to include up to 33 Spiritleaf retail cannabis stores, of which eight will be corporate-owned outlets," said Darren Bondar, President and CEO of Inner Spirit.

"We continue to implement our business strategy by efficiently and effectively opening franchised and corporate-owned Spiritleaf retail cannabis stores in key locations across the country. We are operating in four provinces and growing our brand presence with 33 Spiritleaf stores projected to be fully operating by the end of the third quarter and more than 40 by the end of this year. Our franchise model, bolstered by selectively located corporate stores in jurisdictions where they are permitted, is proving to be effective in helping us deliver top-quality retail shopping experiences to more than 250,000 Spiritleaf customers to date. We have strong support from our key strategic partners and shareholders – Auxly, HEXO and Tilray – and we remain laser-focused on expanding our retail network, enhancing our financial performance and creating value for shareholders," said Bondar.

Vapen MJ (OTCQX:VAPNF) (CSE: VAPN) a fully integrated agricultural technology, services and property management company in the regulated cannabis industry, announced that it has been granted patent #10,231,948 for their metered dose inhaler from the United States Patent and Trademark office.

This utility patent has simply one claim, "an inhaler system consisting essentially of an actuator, a user interchangeable canister assembly, purified cannabinoid from cannabis, isolated terpene, ethanol, and a hydrofluorocarbon propellant.  This patent is valid until 2038.  Vapen MJ also has an unpublished patent pending for additional claims on the inhaler system.

Vapen MJ is currently also doing white label production of the CBD Inhaler and hopes to partner and/or license the patent to a high-volume manufacturer that can reach more of the market with the intrinsic benefits of the Inhaler delivery method.

The patent covers the Company's THC and CBD inhaler device which uses a propellant to atomize the THC or CBD oil so it can be deposited in the lungs, without heat. Vapen's inhalers offer a safe, easy-to-use alternative to smoking, using edibles or other traditional methods of consuming THC or CBD products. The Vapen inhaler administers a pressurized, metered 10 milligram (mg) dose of pharmaceutical grade pure THC or CBD Isolate. The result is a simple, convenient and accurate delivery system.

 "We are very satisfied with the scope of this patent covering the device, the delivered content, and the use of a propellant, all key elements that enable this safe and convenient inhaler to give customers simply the best way to get a precise and measured dose," commented Thai Nguyen, Founder and Chief Executive Officer of Vapen MJ Ventures. "This broad utility patent brings tremendous value to our Company and our brand, as well as new opportunities to drive sales, expand our market presence, and increase shareholder value."

Digipath, Inc. (OTCQB: DIGP), a leading independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, announced that GroSciences, its wholly owned subsidiary, has successfully completed beta-testing of its “Tru-Hemp ID” kit. Tru-Hemp ID distinguishes hemp cultivars from drug-type I cannabis (which are different genetic cultivars of cannabis) via a DNA test of the plant sample.

Under the 2018 Farm Bill that legalized hemp cultivation, hemp is defined as having less than 0.3% delta-9-THC by dry weight.  As a result, compliance with the 2018 Farm Bill is usually determined by analyzing the THC content of a particular plant sample.  Tru-Hemp ID offers a simpler method for determining the strain of a particular plant in the form of a genetic test.  A full analysis of all data collected thus far using the Tru-Hemp ID kit that correlates the genetic outcome of samples with their actual THC content will be forthcoming.

“Hemp farmers in North Carolina and Vermont were very receptive to using the Tru-Hemp ID kit,” stated Cindy S. Orser, PhD, Chief Science Officer, Digipath, Inc.  “Farmers want to have the ability to definitively verify what they are buying, particularly when purchasing hemp seeds from other states or countries, or cannabis clones.”

Dr. Orser also spent time with the Vermont Department of Agricultural staff, including the Vermont hemp program director, Cary Giguere.  Vermont, a progressive cannabis state, already provides for the use of genetic testing to discriminate hemp cultivars from drug-type I cannabis in lieu of a chemical analysis of the mature flower for delta-9-THC content under the 2018 Farm Bill.

“It is rewarding to see our first genetic product entering a successful beta test phase,” added Dr. Orser. “We are enthusiastic about the market opportunity and the interest from hemp farmers and hemp regulators.”

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) the first and only cannabis company with  sales in Canada, the US and the EU, today announced the signing of definitive agreements for a series of transactions to purchase ABI SF, LLC, which operates a Bay Area cannabis cultivation facility and owns the State Flower brand. State Flower is known for its ultra-premium cannabis flower and is currently sold through dispensaries in California and Nevada, including The Apothecarium. TerrAscend recently closed a series of transactions with The Apothecarium as noted in the Company's press release of June 6, 2019. By agreeing to purchase State Flower and bring aboard elite cultivation talent, TerrAscend will continue to provide high quality product through its retail locations and will expand the State Flower brand in multiple states.

TerrAscend has agreed to initially acquire 49.9% of the equity of State Flower for total consideration of US$2.85M from conversion of a previously issued convertible debenture and subject to regulatory approvals.

TerrAscend has also extended a line of credit of up to US$3.75M to State Flower for cultivation facility improvements to expand production capacity.  While State Flower implements facility improvements, the parties will begin the regulatory approval process for the full purchase of State Flower, under a Securities Purchase Agreement.  TerrAscend also has future rights to use the State Flower brand pursuant to a license agreement.  

TerrAscend has agreed to purchase the remaining 50.1% equity of State Flower for total consideration based on future revenue over a predetermined twelve-month period.  The transaction is subject to regulatory approvals by various local and state authorities, as well as certain customary closing conditions.  Several of the owners of The Apothecarium and their related entities have an ownership interest in State Flower.

"We're excited to add the prestigious State Flower brand to our portfolio," said Matthew Johnson, President of TerrAscend Corp., and TerrAscend USA, Inc. "Daniel Wacks and Jeremy Cohen are skilled cannabis cultivators with years of experience operating in a highly regulated market and we are thrilled to work with them to expand the State Flower facilities and brand presence. "

"Through our work with The Apothecarium and TerrAscend, it's clear that we've found a great strategic and cultural fit," said Daniel Wacks, President of State Flower. "We're proud of the brand we've built and excited to have found a partner who recognizes the quality of our team. We look forward to working together to build best-in-class cultivation capabilities in all jurisdictions where TerrAscend operates, to expand the State Flower brand presence, and become part of an inspirational team that's making major progress towards becoming one of the top companies in the sector."

CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF), a North American cannabis products and brands company today announced its financial results for the three and six-month periods ended June 30, 2019. All figures are reported in Canadian dollars ($), unless otherwise indicated. Origin House's financial statements are prepared in accordance with International Financial Reporting Standards.

For a more comprehensive overview of the Corporate and Financial highlights presented in this press release, please refer to Origin House's Management Discussion and Analysis of the Financial Condition and Results of Operations for the three and six months ended June 30, 2019, and the Company's Condensed Interim Consolidated Financial Statements for the three and six months ended June 30, 2019, which will be filed on SEDAR by August 29, 2019.

Marc Lustig, Chairman and CEO of Origin House commented, "I am very proud of the entire Origin House team for generating another quarter of record revenue growth, leveraging the California brand support and distribution platform we built over the past several years, to deliver results for shareholders. It speaks to the strength and maturity of our organization that we were able to increase our share of shelf in California while preparing to integrate with Cresco Labs. To that end, in this quarter, we successfully executed on the sale of Alternative Medical Enterprises LLC generating a 156% return on investment, our distribution division Continuum entered into a distribution agreement with Cresco and began distributing Cresco branded products across California, and we have made substantial progress on post-closing groundwork."

Mr. Lustig continued, "In California, we have built a foundation that is capable of supporting a much larger business and expect to begin to drive significant operating leverage as we continue to grow revenue. With additional regulatory pressure on the illegal market in California, we expect 2020 to be a big year in the state. I am as confident as ever that the combination of Cresco Labs' scale, expertise and brand portfolio with Origin House's proven track record of leveraging our California-wide distribution footprint, is the best way for shareholders to participate in this growth. Together, we will be well-positioned to build a national, and one day, global house of brands."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411

  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories









Sector Snapshot - The Lucrative #CBD #Pet Products Market (OTC: $HIPH) (OTC: $LRSV) (OTC: $MJNA) (OTC: $EDXC)

Sector Snapshot - The Lucrative #CBD #Pet Products Market (OTC: $HIPH) (OTC: $LRSV) (OTC: $MJNA) (OTC: $EDXC)

Point Roberts WA, Delta BC – August 28, 2019 - Investorideas.com, a leading investor news resource covering cannabis and pet stocks releases a snapshot reporting on the continued growth in both product development and availability in the CBD pet product market as more companies enter the space and consumer awareness and demand increase.



In a recent news article, “In the U.S., sales of CBD products for all species are approaching US$500 million, reported David Lummis, lead pet market analyst for Packaged Facts, in a column in Pet Product News. Citing data reported by the Washington Post, he said those sales are projected to soar to as much as US$22 billion by 2024.”

The article continued, Packaged Facts’ own data shows that sales of CBD products for pets specifically are only a fraction of the total, about U.S.$25 million, but growing quickly. Among U.S. pet owners surveyed by Packaged Facts, 39% of dog owners and 34% of cat owners agree they like the idea of CBD supplements for their pets. Additionally, 29% of dog and cat owners agree they would be interested in purchasing CBD supplements for their pets if they were legal.”

“Through the years, the pet supplements market has benefited from the popularization and cross-over of various ingredients from the human side, such as glucosamine and omega fatty acids,” says David Sprinkle, research director for Packaged Facts. “Looking back, however, it’s hard to recall anything making more of a splash in both human and pet supplements than CBD.”

American Premium Water Corporation (OTC: HIPH) recently announced that its Lynks CBD Pet Water, a joint venture with Link Reservations Inc. (OTC: LRSV) is now available for sale on SingleSeed.com.  The Company is launching Lynks CBD a day earlier than the previously announced date of August 29th. The CBD used in this product is hemp-derived.


American Premium Water Corporation CEO, Ryan Fishoff stated “I’m happy to announce that Lynks CBD Pet Water is now available for sale on SingleSeed.com! This product was fast tracked for development in the spring, and we were able to deliver it early! Beverages designed for pets has been an overlooked category in the pet space. There are very few pre-packaged waters designed for pets available in the marketplace, and certainly none that are infused with our proprietary Hydro Nano CBD technology. I am confident that Lynks CBD will quickly establish itself as the market leader in the pet sector. We’re really excited that the Company now has a product to enter the pet market, one of the largest consumer markets in the world.”

Rene Lauritsen, CEO of LinkRes Pets commented, “Today is a great day for our Company. We are excited to expand our offerings for pets and enter the pet beverage market. This product is quite revolutionary; there aren’t many pet beverages on the market, and we are quite confident we will be able to grab significant market share with this product. We have received a number of inquiries from retailers looking to carry this product; I look forward to working with Ryan and his team on fully developing the distribution strategy for Lynks CBD Pet Water.”    

The American Pet Products Association estimates that the US pet product industry will be worth over $75 billion in 2019. The Brightfield Group projects that the CBD Pet Product Market will represent over $1.5 billion in sales, of an estimated $23 billion CBD market by 2023. Pet owners are typically more affluent, as a research report by Research and Marketing estimates that over 55% of US households own a pet, and of that group, they are more likely to be in a higher income household than non-pet owners.

CBD Unlimited, Inc., formerly known as Endexx Corporation (OTC: EDXC), a provider of innovative phytonutrient-based food and nutritional products, recently exhibited at SuperZoo.

At SuperZoo, the Company exhibited its veterinarian-approved Phyto-Bites and Soft Chew CBD pet products which are THC-free, neither heated nor baked, and involve a dual-delivery method to provide effective and safe absorption. CBD Unlimited looks forward to continuing to promote this unique product line and highlighting the benefits that cats and dogs can receive from CBD.

CBD Unlimited's Chief Medical Officer, Dr. Daniel Kiddy, has assisted the Company with its analysis of cannabinoids and its effects on each delivery system. From years of continuous research, CBD Unlimited prides itself on formulating properly dosed products ranging across several pet sizes including cats, dogs and horses. The Company’s one-of-a-kind technology delivers CBD to both CB1 and CB2 receptors in the Endocannabinoid System. 

“CBD Unlimited is passionate about formulating the best products for our four-legged friends that provide optimal results,” CEO & Chairman Todd Davis stated. “Our CBD-infused Soft Chews are proven to have one of the most expeditious and effective delivery systems. We are excited about this opportunity to demonstrate the positive effects of CBD for families’ loved ones.”

Medical Marijuana, Inc. (OTC: MJNA), recently announced that its subsidiary HempMeds® has released its Hemp for Pets pet cannabidiol (CBD) product line in celebration of National Dog Day.

Hemp for Pets by HempMeds® was created to help improve the lives of all pets, from nose to tail. The Company, a proud member of the National Pet Supplement Council (NPSC), aims to improve the lives of pets and people naturally with a commitment to ethically-sourced hemp CBD extract and natural ingredients, dedicated scientific expertise and innovation backed by the strictest efficacy testing.

"We don't just want to create great products, we want to do great work. National Dog Day isn't just a great opportunity to celebrate the dogs who have become a part of our family, but also recognize the many dogs who are currently in need of homes or care. There are so many pet parents, rescues and shelters that HempMeds® can now aid by providing them with the CBD products they need to help improve the wellness of their pets," said HempMeds® President, Todd Morrow. "This is very near to my heart and I am looking forward to spearheading this initiative through our Animals in Need Program."

According to Nielsen analysts, the US pet food and treats market in 2018 reached nearly $33 billion across various retail channels, including local pet stores, vet clinics, e-commerce sites and more. Compared to 2017 sales, this represents a five percent, or $1.5 billion, increase. The Brightfield Group recently reported that the US CBD pet product market was worth $32 million in 2018 and is estimated to grow to at least $1.16 billion by 2022.

"There are many studies providing evidence that CBD has a variety of wellness benefits for pets including improved cardiovascular function, neurological health and behavior, healthy joints and hips, and healthy skin and coats," said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. "Our pet-focused products are made with the Company's Triple Lab Tested™ full-spectrum hemp oil and THC-free isolate to offer pets the same high quality that we've been providing to humans for many years."

The company also recently attended SuperZoo, the most-attended pet industry show in North America, in Las Vegas, August 20-22.

This rise in demand is bringing everyone to the market including GCH, Inc., the development company co-founded by Willie Nelson and his wife, Annie Nelson, which is adding another brand to its portfolio of popular cannabis and hemp product lines, Willie’s Rescue, an array of hemp products for internal and external use in dogs, cats and horses.

“Our mission is to utilize the benefits of the hemp plant to positively impact the lives of companion animals,” said Elizabeth Hogan, Vice President of Brands for GCH, Inc.

This brand also debuted at SuperZoo at the Mandalay Bay Resort in Las Vegas.

“As longtime animal advocates and pet owners, our family believes that the hemp plant has benefited our own animals,” the Nelsons said in a statement. “We want you and your best friends to experience the potential benefits of hemp. That’s why we created Willie’s Rescue and are donating a portion of each sale to help find loving homes for animals in need.”

While CBD products may remain in somewhat of a grey area legally, consumer demand is driving this industry forward with the pet segment taking up a larger and larger segment. People love their pets and it seems most pet owners want the option of quality CBD pet products, and through some companies recent developments, they’re now having more and more options to choose from.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  

Disclaimer/Disclosure Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring HIPH is a paid for news release on Investorideas.com – third party . Learn more about costs and our  services https://www.investorideas.com/News-Upload/  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com   
800-665-0411



Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories



Tuesday, 27 August 2019

Investorideas.com - Cannabis Stock News: Greenlane (Nasdaq: $GNLN) Announces Exclusive U.S. Distribution Partnership for Bouquet Full Spectrum CBD Oil Products

Investorideas.com - Cannabis Stock News: Greenlane (Nasdaq: $GNLN) Announces Exclusive U.S. Distribution Partnership for Bouquet Full Spectrum CBD Oil Products

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move: Interview with Matt Markiewicz, The Cannabis ETF (NYSE: $THCX)


Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move: Interview with Matt Markiewicz, The Cannabis ETF (NYSE: $THCX)



Delta, Kelowna, BC –August 27, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today's podcast overview/transcript

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast I interviewed Matt Markiewicz, the Managing Director of Innovation Shares which also manages The Cannabis ETF (NYSE: THCX), regarding the recent news surrounding THCX as well as the cannabis industry in general.

The Cannabis ETF (THCX) is an ETF that provides investors with a liquid and diversified vehicle to gain access to the explosive growth of the legal cannabis market.

There are a lot of ETF firms out there and over 2k ETFs in the United States. What makes Innovation Shares different?
“The unique thing about Innovation shares is how we build the index that the fund attracts. Part of our methodology is using a patent pending process that applies a natural language processing algorithm, that’s rooted in artificial intelligence, that looks at media sentiment for stocks related to a particular theme. We are trying to only include stocks with positive sentiment. Investor sentiment/behaviour is often influenced by what the media says about the stocks. We apply this process, what’s called a sentiment overlay, into the construction of our portfolios. That’s what really differentiates us.”
What are some of the other factors that influence their decisions to add or remove certain companies from the ETF?
“A stock must a have a minimum 100 million dollar market cap U.S. in order to even be considered in the portfolio. It also has to trade on one of 5 exchanges in the world, which are the ASX, TSX, TSX-V, NYSE or NASDAQ. We also have liquidity requirements as well and we rebound this portfolio monthly and we apply a modified market cap approach.”
Your ETF has had a fair amount of movement in the last few months, could you discuss some of that in detail?
“We did have a fairly active reshuffling of the portfolio this past rebalance. We added Valens, CBDMD, Fire and Flower as well as a company called Enwave who has a proprietary drying technology used in food which is now being applied to cannabis, which is quite an interesting story. We also removed Innovative Industrial Properties and Canntrust. It was a very active rebalance period for us. That’s not always going to be the case but there were a lot of big news items, some bad some good for the cannabis industry over this summer, so that’s why you’re seeing a lot of activity.”
When looking at the proposed Safe |banking Act, how much do you see this impacting the U.S. cannabis industry as well as your ETF?
“The question for us is will the potential passage of the safe banking act allow companies easier access to capital markets, or in other word list on the NYSE or NASDAQ. As I mentioned we have a requirement that stocks have to trade on one of those exchanges. From a funds specific standpoint I think it would be massive. From a broader perspective, it would open up the market to the larger equity space.Right now you’re still not seeing many of the largest fund managers in the world getting involved with cannabis. If the safe banking act will allow those institutions to become more comfortable with owning the stock of these public companies, then this could be a watershed moment for the industry.”
The U.S. and Canada get a large spotlight in the Cannabis industry, how much attention are you paying to the international scope of the industry?
“I think the growth of the global cannabis story is quite interesting. There are companies that are trading now or will be trading soon that will have access to these global markets. As regulatory changes occur in markets around the world, they definitely bare watching. It's going to be an opportunity for revenue expansions, or multiple expansions for the companies entrenching themselves in these markets.” When asked which companies are included in the ETF on an international level Matt included, Khiron Life Sciences and Pharmacielo.
To find out more information regarding the Cannabis ETF, visit their website here.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411

  



Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories




Trial Could Position Eco-Friendly Fertilizer for Organic Cannabis Market

Trial Could Position Eco-Friendly Fertilizer for Organic Cannabis Market